Idera Pharmaceuticals, INC.
SEC CIK 861838 · IDRA · last insider filing 2023-08-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Milano Vincent | Director · President and CEO | filed 2014 - 2023 |
| Gowen Maxine | Director | filed 2016 - 2023 |
| Zein Youssef EL | Director | filed 2006 - 2023 |
| Pillar Invest Corp | Director | filed 2011 - 2023 |
| Taylor John Clayton | Director · Chief Executive Officer | filed 2022 - 2023 |
| Wooten Ronald J | Director | filed 2022 - 2023 |
| NQ POF V GP, Ltd. | Director | filed 2022 - 2023 |
| Novaquest Co-Investment Fund XV, L.P. | Director | filed 2022 - 2023 |
| Dougherty Michael R | Director | filed 2019 - 2023 |
| Geraghty James A | Director | filed 2013 - 2022 |
| Schafer Carol | Director | filed 2018 - 2022 |
| Csimma Cristina | Director | filed 2019 - 2022 |
| Goldberg Mark Alan | Director | filed 2014 - 2022 |
| Pien Howard H | Director | filed 2018 - 2020 |
| Pillar Pharmaceuticals I LP | Director | filed 2011 - 2020 |
| Pillar Pharmaceuticals II, L.P. | Director | filed 2012 - 2020 |
| Pillar Pharmaceuticals III, L.P. | Director | filed 2013 - 2020 |
| Pillar Pharmaceuticals IV, L.P. | Director | filed 2013 - 2020 |
| Pillar Pharmaceuticals V LP | Director | filed 2016 - 2020 |
| Baker Julian | Director | filed 2006 - 2019 |
| Baker Felix | Director | filed 2006 - 2019 |
| Baker Bros. Advisors LP | Director | filed 2014 - 2019 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2014 - 2019 |
| Baker Brothers Life Sciences LP | Director | filed 2014 - 2019 |
| 14159, L.P. | Director | filed 2014 - 2019 |
| 667, L.P. | Director | filed 2014 - 2019 |
| Reardon William S | Director | filed 2006 - 2018 |
| Agrawal Sudhir | Director · President of Research | filed 2006 - 2017 |
| Slater Eve Elizabeth | Director | filed 2010 - 2015 |
| Maccoss Malcolm | Director | filed 2010 - 2014 |
| Karr Robert W | Director · President | filed 2006 - 2014 |
| Abdul-Wahab Umari | Director | filed 2012 - 2014 |
| Neu Kelvin | Director | filed 2014 - 2014 |
| Hartley C Keith | Director | filed 2006 - 2013 |
| Wyngaarden James B | Director | filed 2006 - 2011 |
| Mueller Hans | Director | filed 2007 - 2011 |
| Rigby Alison Taunton | Director | filed 2006 - 2009 |
| Zamecnik Paul C | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Jordan Andrew R | Chief Strategy Officer | filed 2022 - 2023 |
| Kirby John J. | VP of Finance | filed 2018 - 2023 |
| Lim Bryant David | SVP and General Counsel | filed 2018 - 2023 |
| Salain Daniel | Chief Operating Officer | filed 2022 - 2023 |
| Kraus Carl N | Chief Medical Officer | filed 2022 - 2023 |
| Soland Daniel B | Chief Operating Officer | filed 2021 - 2022 |
| Tarka Elizabeth Ann | Chief Medical Officer | filed 2019 - 2021 |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | filed 2015 - 2020 |
| Yingling Jonathan Michael | SVP, Early Development | filed 2017 - 2020 |
| Horobin Joanna | SVP and Chief Medical Officer | filed 2015 - 2019 |
| Arcudi Louis J. | Chief Financial Officer | filed 2007 - 2018 |
| Casey Mark J | Senior VP and General Counsel | filed 2015 - 2018 |
| Brenner Louis MD | Chief Medical Officer | filed 2014 - 2014 |
| Wolf John Peter III | General Counsel | filed 2014 - 2014 |
| Sullivan Timothy M | VP Development Programs | filed 2006 - 2014 |
| Arbeit Robert D. | VP Clinical Development | filed 2010 - 2013 |
| Bexon Alice | V.P. Clinical Development | filed 2007 - 2009 |
| Andersen Robert G | CFO & VP Oper. and Planning | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.